Impact of Buzhong Yiqi Prescription on the Gut Microbiota of Patients with Obesity Manifesting Polycystic Ovarian Syndrome

Gut microbiota disorders are closely related to polycystic ovarian syndrome (PCOS). Buzhong Yiqi prescription (BZYQ) has a significant clinical effect on the treatment of patients with obesity exhibiting PCOS and phlegm-dampness syndrome caused by spleen deficiency (SPSD). Hence, this study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Zhexin, Cheng, Wen, Ding, Jie, Yao, Ruipin, Zhang, Danying, Zhai, Dongxia, Zhou, Ling, Yu, Chaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984899/
https://www.ncbi.nlm.nih.gov/pubmed/33790981
http://dx.doi.org/10.1155/2021/6671367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984899/
https://www.ncbi.nlm.nih.gov/pubmed/33790981
http://dx.doi.org/10.1155/2021/6671367

Ejemplares similares